Thompson1999: Trials on Serum Cholesterin Concentration Lowering and Risk...

Thompson1999R Documentation

Trials on Serum Cholesterin Concentration Lowering and Risk of Ischaemic Heart Disease

Description

Results from 28 trials evaluating effect of serum cholesterin concentration lowering on risk of ischaemic heart disease

Usage

Thompson1999

Format

The data frame contains the following columns:

studyid integer study ID
ihd.cont integer number of ischaemic heart disease (control group)
noihd.cont integer number of non-events (control group)
ihd.exp integer number of ischaemic heart disease (treated group)
noihd.exp integer number of non-events (treated group)
OR numeric odds ratio
logOR numeric log odds ratio
varlogOR numeric variance of log odds ratio
cholr numeric cholesterol reduction (mmol/l)

Details

Thompson & Sharp (1999) compare several meta-regression approaches to explain heterogeneity in meta-analysis. The data set used goes back to Law et al. (1994).

Concepts

epidemiology, odds ratios, meta-regression

Author(s)

Guido Schwarzer, guido.schwarzer@uniklinik-freiburg.de

Source

Thompson, S. G. Sharp, S. J. (1999). Explaining heterogeneity in meta-analysis: a comparison of methods. Statistics in Medicine, 18: 2693-708

References

Law, M.R., Wald, N.J., Thompson, S.G. (1994). By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? British Medical Journal, 308, 367-73

Examples


if (requireNamespace("meta", quietly = TRUE)) {
# Load meta package
library("meta")

# Conduct meta-analysis
ma <- metabin(ihd.exp, ihd.exp + noihd.exp, ihd.cont, ihd.cont + noihd.cont,
  data = Thompson1999, sm = "OR", method = "Inverse")

# Thompson & Sharp (1999), Table III
# (1) None
metareg(ma, cholr, method.tau = "FE")
# (3a) Additive (MM)
metareg(ma, cholr, method.tau = "DL")
}


metabook documentation built on March 13, 2026, 5:06 p.m.